Coronaviruses — drug discovery and therapeutic options

Alimuddin Zumla; Jasper Fuk‐Woo Chan; Esam I. Azhar; David S.C. Hui; Kwok‐Yung Yuen

doi:10.1038/nrd.2015.37

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug discovery2019-20 coronavirus outbreakDrugCoronavirusVirologyMedicineBusinessPharmacologyBioinformaticsBiologyInternal medicineInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Yadi Zhou , Yuan Hou , Jiayu Shen +3 more

Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epi...

2020 Cell Discovery 1664 citations

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Li Tan , Qi Wang , Duanyang Zhang +5 more

Background: Coronavirus disease-2019 (COVID-19) is a rapidly escalating epidemic caused by SARS-CoV-2. Identification of a simple and effective indicator to assess disease sever...

2020 Signal Transduction and Targeted Therapy 1583 citations

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu , Hua Guo , Peng Zhou +1 more

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute re...

2020 Nature Reviews Microbiology 5269 citations

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

Bindu Bennet , Jayanthi Wolf , Rodrigo Laureano +1 more

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an ur...

2020 Toxicologic Pathology 47 citations

Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection

Vincent Chi‐Chung Cheng , Susanna K. P. Lau , Patrick C. Y. Woo +1 more

SUMMARY Before the emergence of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) in 2003, only 12 other animal or human coronaviruses were known. The discovery of...

2007 Clinical Microbiology Reviews 1215 citations

Publication Info

Year: 2016
Type: review
Volume: 15
Issue: 5
Pages: 327-347
Citations: 1764
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Coronaviruses — drug discovery and therapeutic options

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1764

OpenAlex

Cite This

APA Style

                            
                                
                                    Alimuddin Zumla, 
                                
                                    Jasper Fuk‐Woo Chan, 
                                
                                    Esam I. Azhar
                                
                                et al.
                            
                            (2016). 
                            Coronaviruses — drug discovery and therapeutic options. 
                            Nature Reviews Drug Discovery
                            , 15
                            (5)
                            , 327-347.
                            https://doi.org/10.1038/nrd.2015.37
                        

Identifiers

DOI: 10.1038/nrd.2015.37